BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 29156385)

  • 1. Interaction with the GDF8/11 pathway reveals treatment options for adenocarcinoma of the breast.
    Wallner C; Drysch M; Becerikli M; Jaurich H; Wagner JM; Dittfeld S; Nagler J; Harati K; Dadras M; Philippou S; Lehnhardt M; Behr B
    Breast; 2018 Feb; 37():134-141. PubMed ID: 29156385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for potency differences between GDF8 and GDF11.
    Walker RG; Czepnik M; Goebel EJ; McCoy JC; Vujic A; Cho M; Oh J; Aykul S; Walton KL; Schang G; Bernard DJ; Hinck AP; Harrison CA; Martinez-Hackert E; Wagers AJ; Lee RT; Thompson TB
    BMC Biol; 2017 Mar; 15(1):19. PubMed ID: 28257634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of the WFIKKN2 follistatin domain reveals insight into how it inhibits growth differentiation factor 8 (GDF8) and GDF11.
    McCoy JC; Walker RG; Murray NH; Thompson TB
    J Biol Chem; 2019 Apr; 294(16):6333-6343. PubMed ID: 30814254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follistatin dysregulation impaired trophoblast biological functions by GDF11-Smad2/3 axis in preeclampsia placentas.
    Li H; Zhou L; Zhang C; Xi Q; Lv J; Huo W; Zhu L; Zhu R; Zhang Y
    Placenta; 2022 Apr; 121():145-154. PubMed ID: 35339026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GDF11 promotes osteogenesis as opposed to MSTN, and follistatin, a MSTN/GDF11 inhibitor, increases muscle mass but weakens bone.
    Suh J; Kim NK; Lee SH; Eom JH; Lee Y; Park JC; Woo KM; Baek JH; Kim JE; Ryoo HM; Lee SJ; Lee YS
    Proc Natl Acad Sci U S A; 2020 Mar; 117(9):4910-4920. PubMed ID: 32071240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional substitutions of amino acids that differ between GDF11 and GDF8 impact skeletal development and skeletal muscle.
    Lian J; Walker RG; D'Amico A; Vujic A; Mills MJ; Messemer KA; Mendello KR; Goldstein JM; Leacock KA; Epp S; Stimpfl EV; Thompson TB; Wagers AJ; Lee RT
    Life Sci Alliance; 2023 Mar; 6(3):. PubMed ID: 36631218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of Circulating Growth and Differentiation Factors 8 and 11 and Their Antagonists as Measured Using Liquid Chromatography-Tandem Mass Spectrometry With Age and Skeletal Muscle Strength in Healthy Adults.
    Semba RD; Zhang P; Zhu M; Fabbri E; Gonzalez-Freire M; Carlson OD; Moaddel R; Tanaka T; Egan JM; Ferrucci L
    J Gerontol A Biol Sci Med Sci; 2019 Jan; 74(1):129-136. PubMed ID: 30380014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships of GDF8 and 11 and Their Antagonists With Decline of Grip Strength Among Older Adults in the Baltimore Longitudinal Study of Aging.
    Yamaguchi Y; Zhu M; Moaddel R; Palchamy E; Ferrucci L; Semba RD
    J Gerontol A Biol Sci Med Sci; 2023 Oct; 78(10):1793-1798. PubMed ID: 37235639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential antagonism of activin, myostatin and growth and differentiation factor 11 by wild-type and mutant follistatin.
    Schneyer AL; Sidis Y; Gulati A; Sun JL; Keutmann H; Krasney PA
    Endocrinology; 2008 Sep; 149(9):4589-95. PubMed ID: 18535106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The differential anti-tumour effects of zoledronic acid in breast cancer - evidence for a role of the activin signaling pathway.
    Wilson C; Ottewell P; Coleman RE; Holen I
    BMC Cancer; 2015 Feb; 15():55. PubMed ID: 25884855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration of rGDF11 retards the aging process in male mice via action of anti-oxidant system.
    Zhou Y; Song L; Ni S; Zhang Y; Zhang S
    Biogerontology; 2019 Aug; 20(4):433-443. PubMed ID: 30726519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both WFIKKN1 and WFIKKN2 have high affinity for growth and differentiation factors 8 and 11.
    Kondás K; Szláma G; Trexler M; Patthy L
    J Biol Chem; 2008 Aug; 283(35):23677-84. PubMed ID: 18596030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GDF11 exhibits tumor suppressive properties in hepatocellular carcinoma cells by restricting clonal expansion and invasion.
    Gerardo-Ramírez M; Lazzarini-Lechuga R; Hernández-Rizo S; Jiménez-Salazar JE; Simoni-Nieves A; García-Ruiz C; Fernández-Checa JC; Marquardt JU; Coulouarn C; Gutiérrez-Ruiz MC; Pérez-Aguilar B; Gomez-Quiroz LE
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1540-1554. PubMed ID: 30890427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similar sequences but dissimilar biological functions of GDF11 and myostatin.
    Suh J; Lee YS
    Exp Mol Med; 2020 Oct; 52(10):1673-1693. PubMed ID: 33077875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemistry and Biology of GDF11 and Myostatin: Similarities, Differences, and Questions for Future Investigation.
    Walker RG; Poggioli T; Katsimpardi L; Buchanan SM; Oh J; Wattrus S; Heidecker B; Fong YW; Rubin LL; Ganz P; Thompson TB; Wagers AJ; Lee RT
    Circ Res; 2016 Apr; 118(7):1125-41; discussion 1142. PubMed ID: 27034275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of follistatin and FLRG in human breast proliferative disorders.
    Bloise E; Couto HL; Massai L; Ciarmela P; Mencarelli M; Borges LE; Muscettola M; Grasso G; Amaral VF; Cassali GD; Petraglia F; Reis FM
    BMC Cancer; 2009 Sep; 9():320. PubMed ID: 19740438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Expression of Follistatin in Breast Cancer Reduces Invasiveness and Clinically Correlates with Better Survival.
    Zabkiewicz C; Resaul J; Hargest R; Jiang WG; Ye L
    Cancer Genomics Proteomics; 2017; 14(4):241-251. PubMed ID: 28647698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GDF11 Increases with Age and Inhibits Skeletal Muscle Regeneration.
    Egerman MA; Cadena SM; Gilbert JA; Meyer A; Nelson HN; Swalley SE; Mallozzi C; Jacobi C; Jennings LL; Clay I; Laurent G; Ma S; Brachat S; Lach-Trifilieff E; Shavlakadze T; Trendelenburg AU; Brack AS; Glass DJ
    Cell Metab; 2015 Jul; 22(1):164-74. PubMed ID: 26001423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between serum level of growth differentiation factors 8, 11 and bone mineral density in girls with anorexia nervosa.
    Wu Y; Qu J; Li H; Yuan H; Guo Q; Ouyang Z; Lu Q
    Clin Endocrinol (Oxf); 2019 Jan; 90(1):88-93. PubMed ID: 30281844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential Binding Activity of TGF-β Family Proteins to Select TGF-β Receptors.
    Khalil AM; Dotimas H; Kahn J; Lamerdin JE; Hayes DB; Gupta P; Franti M
    J Pharmacol Exp Ther; 2016 Sep; 358(3):423-30. PubMed ID: 27340210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.